已发表的部分文献: 标题:Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.作者:Zhang C, Zhang M, Ge S, Huang W, Lin X, Gao J, Gong J, Shen L;杂志名称:Cancer Med 标题:Critical roles of mRNA m<sup>6</sup>A modification and YTHDC2 expression for meiotic initiation and progression in female germ cells.作者:Zeng M, Dai X, Liang Z, Sun R, Huang S, Luo L, Li Z;杂志名称:Gene 标题:Interplay of m<sup>6</sup>A and H3K27 trimethylation restrains inflammation during bacterial infection.作者:Wu C, Chen W, He J, Jin S, Liu Y, Yi Y, Gao Z, Yang J, Yang J, Cui J, Zhao W;杂志名称:Sci Adv 标题:Comprehensive Analysis of m5C RNA Methylation Regulator Genes in Clear Cell Renal Cell Carcinoma作者:Wu, J. et. al.;杂志名称:Int'l Journal of Genomics 标题:LncNAP1L6 activates MMP pathway by stabilizing the m6A-modified NAP1L2 to promote malignant progression in prostate cancer.作者:Zheng Y, Qi F, Li L, Yu B, Cheng Y, Ge M, Qin C, Li X;杂志名称:Cancer Gene Ther 标题:Peptides targeting RNA m6A methylations influence the viability of cancer cells.作者:Rauff R, Abedeera S, Schmocker S, Xie J, Abeysirigunawardena S;杂志名称:ChemMedChem 标题:Kar4, the Yeast Homolog of METTL14, is Required for mRNA m (6) A Methylation and Meiosis.作者:Park ZM, Sporer A, Kraft K, Lum K, Blackman E, Belnap E, Yellman C, Rose MD;杂志名称:bioRxiv 标题:METTL3/YTHDF1 m(6)A axis promotes tumorigenesis by enhancing DDR2 expression in ovarian cancer.作者:Zhi D, Zhou K, Liu S, Yu W, Dong M, Yan C;杂志名称:Pathol Res Pract Epigentek 公司是全球领先的表观遗传学相关研究的技术创新者和产品开发供应商。开发了超过700多个专利产品,为表观遗传学方面的研究和新药研发提供全面系统的解决方案,涵盖样品制备、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、组蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等领域,提供小分子抑制剂、蛋白质、抗体、以及分析试剂盒产品。